Field & Main Bank Trims Stake in CVS Health Co. (NYSE:CVS)

Field & Main Bank lessened its position in shares of CVS Health Co. (NYSE:CVS) by 30.7% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,185 shares of the pharmacy operator’s stock after selling 1,409 shares during the quarter. Field & Main Bank’s holdings in CVS Health were worth $251,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in CVS. Exchange Traded Concepts LLC boosted its stake in shares of CVS Health by 22.8% during the third quarter. Exchange Traded Concepts LLC now owns 5,993 shares of the pharmacy operator’s stock worth $418,000 after buying an additional 1,112 shares during the period. Brookstone Capital Management increased its holdings in shares of CVS Health by 18.3% in the third quarter. Brookstone Capital Management now owns 60,115 shares of the pharmacy operator’s stock valued at $4,245,000 after purchasing an additional 9,303 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund lifted its holdings in shares of CVS Health by 1.0% during the third quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 335,419 shares of the pharmacy operator’s stock worth $23,419,000 after purchasing an additional 3,400 shares during the period. Sheets Smith Wealth Management grew its position in CVS Health by 10.4% in the 3rd quarter. Sheets Smith Wealth Management now owns 63,875 shares of the pharmacy operator’s stock valued at $4,460,000 after buying an additional 6,009 shares during the last quarter. Finally, Sweet Financial Partners LLC raised its position in CVS Health by 60.2% during the 3rd quarter. Sweet Financial Partners LLC now owns 20,971 shares of the pharmacy operator’s stock worth $1,464,000 after buying an additional 7,877 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Up 0.4 %

Shares of CVS Health stock traded up $0.26 on Monday, hitting $67.44. 6,556,157 shares of the company’s stock traded hands, compared to its average volume of 10,605,164. The company has a quick ratio of 0.63, a current ratio of 0.86 and a debt-to-equity ratio of 0.77. The firm’s 50-day moving average is $74.22 and its 200 day moving average is $73.65. The stock has a market cap of $85.01 billion, a P/E ratio of 10.44, a PEG ratio of 0.89 and a beta of 0.52. CVS Health Co. has a 52-week low of $64.41 and a 52-week high of $83.25.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share for the quarter, topping the consensus estimate of $2.01 by $0.11. The company had revenue of $93.81 billion during the quarter, compared to the consensus estimate of $90.58 billion. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The company’s revenue was up 11.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.99 EPS. Equities analysts anticipate that CVS Health Co. will post 8.31 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd will be issued a $0.665 dividend. The ex-dividend date is Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.94%. CVS Health’s dividend payout ratio (DPR) is 41.18%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the stock. Cantor Fitzgerald reiterated an “overweight” rating and set a $87.00 price target on shares of CVS Health in a research note on Wednesday, April 10th. Leerink Partnrs reissued an “outperform” rating on shares of CVS Health in a report on Monday, February 26th. StockNews.com cut CVS Health from a “buy” rating to a “hold” rating in a research report on Thursday, February 15th. Wells Fargo & Company decreased their target price on shares of CVS Health from $83.00 to $76.00 and set an “equal weight” rating on the stock in a research report on Monday, April 8th. Finally, Royal Bank of Canada decreased their target price on shares of CVS Health from $86.00 to $84.00 and set an “outperform” rating on the stock in a research report on Thursday, February 8th. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $89.44.

Insider Activity at CVS Health

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of the business’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the completion of the sale, the executive vice president now owns 39,765 shares in the company, valued at $3,059,916.75. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.24% of the company’s stock.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.